MENU
Showcases Stock ranks Forex

Zynerba Pharma CS (ZYNE)
1.25  0.03 (2.46%) 08-08 16:00
Open: 1.25 Pre. Close: 1.22
High: 1.39 Low: 1.22
Volume: 703,659 Market Cap: 56M
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.39 - 1.395 1.395 - 1.399
Low: 1.207 - 1.213 1.213 - 1.218
Close: 1.241 - 1.249 1.249 - 1.256
Stock Technical Analysis
Overall:     
Target: Six months: 1.62
One year: 1.90
Support: Support1: 1.18
Support2: 1.05
Resistance: Resistance1: 1.39
Resistance2: 1.62
Pivot: 1.18
Moving Averages: MA(5): 1.19
MA(20): 1.16
MA(100): 1.31
MA(250): 2.55
MACD: MACD(12,26): 0.02
Signal(12,26,9): 0.01
%K %D: %K(14,3): 49.22
%D(3): 43.72
RSI: RSI(14): 59.22
52-Week: High: 4.67
Low: 0.836
Change(%): -68.1
Average Vol(K): 3-Month: 551
10-Days: 425
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

[ ZYNE ] has closed below upper band by 4.2%. Bollinger Bands are 58.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Mon, 08 Aug 2022
North American Morning Briefing: Stock Futures -2- - Morningstar

Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 44.86
Shares Float (M) 39.87
% Held by Insiders 4.14
% Held by Institutions 27.28
Shares Short (K) 822
Shares Short Prior Month (K) 946
Stock Financials
EPS -0.962
Book Value (p.s.) 1.590
Profit Margin
Operating Margin
Return on Assets (ttm) -25.8
Return on Equity (ttm) -47.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.837
Qtrly Earnings Growth
Operating Cash Flow (M) -24.96
Levered Free Cash Flow (M) -10.88
Stock Valuation
PE Ratio -1.30
PEG Ratio
Price to Book value 0.79
Price to Sales
Price to Cash Flow -2.25
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android